Metabolic syndrome risk in children decreased 12 percent for each 10 ng increase in Vitamin D – meta-analysis July 2021

Circulating serum vitamin D levels in relation to metabolic syndrome in children: A systematic review and dose-response meta-analysis of epidemiologic studies

Review Obes Rev. 2021 Jul 6. doi: 10.1111/obr.13314
Parisa Rouhani 1 2, Zahra Hajhashemy 1 2, Parvane Saneei 2

Findings from epidemiologic studies that evaluated the relationship between serum vitamin D levels and metabolic syndrome (MetS) in children were contradictory. We conducted a systematic review and meta-analysis on the relation of serum 25(OH)D levels and MetS in children. A comprehensive search was conducted in electronic databases, up to November 2020. Eleven cross-sectional studies that reported the link between circulating vitamin D levels and MetS in children were included in the analysis. Combining 11 effect sizes from 11 cross-sectional studies with 22,196 participants revealed that highest versus lowest serum vitamin D concentration was significantly associated with a 50% reduced odds of MetS in children (OR: 0.50; 95%CI: 0.39, 0.64). Subgroup analysis by study location revealed decreased odds of MetS in both non-Asian (OR: 0.45; 95%CI: 0.33, 0.63) and Asian countries (OR: 0.54; 95%CI: 0.39, 0.76) with no heterogeneity in these subgroups. When we confined the studies to those with representative populations (n = 21,611), a significant inverse association was found between highest versus lowest circulating vitamin D level and MetS (OR: 0.55; 95%CI: 0.42, 0.71).

Dose-response analysis showed that each 10 ng/ml (or 25 nmol/L) in serum vitamin D was linearly related to a 12% reduced odds of MetS (OR: 0.88; 95%CI: 0.78, 0.99) in children. A nonlinear association was also detected between serum 25(OH)D and MetS. This meta-analysis revealed that circulating vitamin D concentration was inversely associated with odds of MetS in children, in a dose-response fashion. The same finding was found in the studies with representative populations.

REFERENCES

1. Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol: WJG. 2011;17(26):3082-3091.
2. Potenza MV, Mechanick JI. The metabolic syndrome: definition, global impact, and pathophysiology. Nutr Clin Pract. 2009;24(5):560-577.
3. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care. 2000;23(4):465-471.
4. Räikkönen K, Matthews KA, Salomon K. Hostility predicts metabolic syndrome risk factors in children and adolescents. Health Psychol. 2003;22(3):279-286.
5. Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: a systematic review of the literature. Metab Syndr Relat Disord. 2013;11(2):71-80. https://doi.org/10.1089/met.2012.0122
6. Marangos P, Okamoto L, Caro J, Preedy V, Watson R. Economic Burden of the Components of the Metabolic Syndrome. In: Handbook of Disease Burdens and Quality of Life Measures. New York, NY: Springer; 2010.
7. Shukla P, Palta S, Gupta A, Sehgal VK. Analysis of cost of medical therapy in patients of metabolic syndrome: an observational study. Int J Res Med Sci. 2018;6(2):443-447.
8. Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC. Prevalence of obesity and severe obesity in US children, 1999-2016. Pediatrics. 2018;141(3):e20173459.
9. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384(9945):766-781.
10. Higuita-Gutiérrez LF, Quiroz WDJM, Cardona-Arias JA. Prevalence of metabolic syndrome and its association with sociodemographic characteristics in participants of a public chronic disease control program in Medellin, Colombia, in 2018. Diab Metab Syn Obes: Target Ther. 2020;13:1161-1169.
11. Goyal RK, Shah VN, Saboo BD, et al. Prevalence of overweight and obesity in Indian adolescent school going children: its relationship with socioeconomic status and associated lifestyle factors. J Assoc Physicians India. 2010;58:151-158.
12. Smetanina N, Albaviciute E, Babinska V, et al. Prevalence of overweight/obesity in relation to dietary habits and lifestyle among 7-17 years old children and adolescents in Lithuania. BMC Public Health. 2015;15(1):1-9.
13. Kursawe R, Santoro N. Metabolic syndrome in pediatrics. Adv Clin Chem. 2014;65:91-142. https://doi.org/10.1016/b978-0-12-800141-7.00004-8
14. Carlson JJ, Eisenmann JC, Norman GJ, Ortiz KA, Young PC. Dietary fiber and nutrient density are inversely associated with the metabolic syndrome in US adolescents. J Am Diet Assoc. 2011;111(11):1688-1695.
15. Kelishadi R, Ardalan G, Motlagh ME, et al. National report on the association of serum vitamin D with cardiometabolic risk factors in the pediatric population of the Middle East and North Africa (MENA): the CASPIAN-III Study. Nutrition. 2014;30(1):33-38.
16. Gupta N, Shah P, Nayyar S, Misra A. Childhood obesity and the metabolic syndrome in developing countries. Indian J Pediatr. 2013;80(1):28-37.
17. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev. 2007;29(1):62-76.
18. Reinehr T, Kleber M, Toschke AM. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis. 2009;207(1):174-180.
19. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr. 2007;26(5):573-580.
20. Boucher B, Mannan N, Noonan K, Hales C, Evans S. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995;38(10):1239-1245.
21. Scragg R, Sowers M, Bell C, Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004;27(12):2813-2818.
22. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005;28(5):1228-1230.
23. Saintonge S, Bang H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics. 2009;123(3):797-803.
24. Eggemoen ÅR, Knutsen KV, Dalen I, Jenum AK. Vitamin D status in recently arrived immigrants from Africa and Asia: a cross-sectional study from Norway of children, adolescents and adults. BMJ Open. 2013;3(10):e003293.
25. Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;1-16.
26. Murni IK, Sulistyoningrum DC, Oktaria V. Association of vitamin D deficiency with cardiovascular disease risk in children: implications for the Asia Pacific Region. Asia Pac J Clin Nutr. 2016;25(Suppl 1):S8-s19. https://doi.org/10.6133/apjcn.122016.s1
27. Bener A, Al-Ali M, Hoffmann GF. Vitamin D deficiency in healthy children in a sunny country: associated factors. Int J Food Sci Nutr. 2009;60(sup5):60-70.
28. Albert Perez E, Mateu Olivares V, Martínez-Espinosa RM, Molina Vila MD, Reig G-GM. New insights about how to make an intervention in children and adolescents with metabolic syndrome: diet, exercise vs. changes in body composition. A systematic review of RCT. Nutrients. 2018;10(7):878.
29. Ashraf AP, Alvarez JA, Gower BA, Saenz KH, McCormick KL. Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females. Obesity. 2011;19(11):2214-2221.
30. Cabral M, Araújo J, Teixeira J, et al. Vitamin D levels and cardiometabolic risk factors in Portuguese adolescents. Int J Cardiol. 2016;220:501-507.
31. Gannagé-Yared M-H, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol. 2009;160(6):965-971.
32. Kwon JH, Lee SE, Lee HA, et al. Relationship of serum 25-Hydroxyvitamin D (25 OH D) levels and components of metabolic syndrome in prepubertal children. Nutrition. 2015;31(11-12):1324-1327.
33. Lee S, Kim SM, Park H, et al. Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children. Nutr Metab Cardiovasc Dis. 2013;23(8):785-791.
34. Pacifico L, Anania C, Osborn J, et al. Low 25 (OH) D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol. 2011;165(4):603-611.
35. Tang Z, Huang S, Ma R, Zheng H, Zhu Y. Low vitamin D status is associated with obesity but no other cardiovascular risk factors in Chinese children and adolescents. Nutr Metab Cardiovasc Dis. 2020;30(9):1573-1581.
36. Nam GE, Kim DH, Cho KH, et al. Estimate of a predictive cut-off value for serum 25-hydroxyvitamin D reflecting abdominal obesity in Korean adolescents. Nutr Res. 2012;32(6):395-402.
37. Reis JP, Von Mühlen D, Miller ER, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics. 2009;124(3):e371-e379.
38. Alemzadeh R, Kichler J. Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents. Metab Syndr Relat Disord. 2012;10(6):422-429.
39. Moreira C, Moreira P, Abreu S, et al. Vitamin D intake and cardiometabolic risk factors in adolescents. Metab Syndr Relat Disord. 2014;12(3):171-177.
40. Petersen RA, Dalskov S-M, Sørensen LB, et al. Vitamin D status is associated with cardiometabolic markers in 8-11-year-old children, independently of body fat and physical activity. Br J Nutr. 2015;114(10):1647-1655.
41. Jalali-Farahani S, Amiri P, Akbar HM, Cheraghi L, Karimi M, Azizi F. Effects of a healthy lifestyle education on the incidence of metabolic syndrome in children during a 13-year follow-up. Int J Behav Med. 2018;25(1):131-140.
42. Al-Daghri NM, Amer OE, Khattak MN, et al. Effects of different vitamin D supplementation strategies in reversing metabolic syndrome and its component risk factors in adolescents. J Steroid Biochem Mol Biol. 2019;191:105378.
43. Makariou SE, Elisaf M, Challa A, Tellis C, Tselepis AD, Liberopoulos EN. Effect of combined vitamin D administration plus dietary intervention on oxidative stress markers in patients with metabolic syndrome: a pilot randomized study. Clin Nutr ESPEN. 2019;29:198-202.
44. Ghobadi S, Rostami ZH, Marzijarani MS, Faghih S. Association of vitamin D status and metabolic syndrome components in Iranian children. Int J Prev Med. 2019:10.
45. Mangge H, Zelzer S, Meinitzer A, et al. 25OH-vitamin D3 levels in obesity and metabolic syndrome-unaltered in young and not correlated to carotid IMT in all ages. Curr Pharm Des. 2015;21(17):2243-2249.
46. Fu J, Han L, Zhao Y, et al. Vitamin D levels are associated with metabolic syndrome in adolescents and young adults: the BCAMS study. Clin Nutr. 2019;38(5):2161-2167.
47. Wells G, Shea B, O'Connell D. Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis; 2000.
48. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301-1309.
49. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006;6(1):40-57.
50. Nam GE, Kim DH, Cho KH, et al. 25-hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008-2009 Korea National Health and Nutrition Examination Survey (KNHANES). Public Health Nutr. 2014;17(1):186-194.
51. Lee DY, Kwon AR, Ahn JM, et al. Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008-2010. Ann Pediatr Endocrinol Metab. 2015;20(1):46-52.
52. Kim Y-S, Hwang JH, Song MR. The association between vitamin D deficiency and metabolic syndrome in Korean adolescents. J Pediatr Nurs. 2018;38:e7-e11.
53. Ganji V, Zhang X, Shaikh N, Tangpricha V. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr. 2011;94(1):225-233.
54. World Health Organization. Non communicable diseases. Available from: https://wwwwhoint/news-room/fact-sheets/detail/noncommunicablediseases Accessed 25 July 2019.
55. (WHO) WHO. World Health Organization (WHO). NCD mortality and morbidity. Global Health Observatory (GHO) data. https://www.who.int/gho/ncd/mortality_morbidity/en/. 2016
56. Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-1044.
57. Cashman KD. Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int. 2019;1-16.
58. Schleicher RL, Sternberg MR, Looker AC, et al. National estimates of serum total 25-hydroxyvitamin D and metabolite concentrations measured by liquid chromatography-tandem mass spectrometry in the US population during 2007-2010. J Nutr. 2016;146(5):1051-1061.
59. Sarafin K, Durazo-Arvizu R, Tian L, et al. Standardizing 25-hydroxyvitamin D values from the Canadian health measures survey. Am J Clin Nutr. 2015;102(5):1044-1050.
60. Stagi S, Pelosi P, Strano M, et al. Determinants of vitamin D levels in Italian children and adolescents: a longitudinal evaluation of cholecalciferol supplementation versus the improvement of factors influencing 25(OH)D status. Int J Endocrinol. 2014;2014:583039. https://doi.org/10.1155/2014/583039
61. Çizmecioğlu FM, Etiler N, Görmüş U, Hamzaoğlu O, Hatun Ş. Hypovitaminosis D in obese and overweight schoolchildren. J Clin Res Pediatr Endocrinol. 2008;1(2):89-96.
62. Rafraf M, Hasanabad SK, Jafarabadi MA. Vitamin D status and its relationship with metabolic syndrome risk factors among adolescent girls in Boukan, Iran. Public Health Nutr. 2014;17(4):803-809.
63. Hu Y, Chen J, Wang R, et al. Vitamin D nutritional status and its related factors for Chinese children and adolescents in 2010-2012. Nutrients. 2017;9(9):1024.
64. Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev. 2013;14(5):393-404.
65. Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr. 2010;64(12):1457-1464. https://doi.org/10.1038/ejcn.2010.176
66. Karhapää P, Pihlajamäki J, Pörsti I, et al. Diverse associations of 25-hydroxyvitamin D and 1, 25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med. 2010;268(6):604-610.
67. Mai X-M, Videm V, Sheehan NA, Chen Y, Langhammer A, Sun Y-Q. Potential causal associations of serum 25-hydroxyvitamin D with lipids: a Mendelian randomization approach of the HUNT study. Eur J Epidemiol. 2019;34(1):57-66.
68. Di Angelantonio ESN, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;18(302):1993-2000. https://doi.org/10.1001/jama.2009.1619
69. Boekholdt SM, Arsenault BJ, Hovingh GK, et al. Levels and changes of HDL cholesterol and apolipoprotein AI in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation. 2013;128(14):1504-1512.
70. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89:387-392.
71. Ardeshir Larijani F, Kalantar Motamedi SM, Keshtkar AA, et al. The relation between serum vitamin D levels and blood pressure: a population-based study. Acta Med Iran. 2014;52(4):290-297.